ADAM17 Regulates p75^NTR-Mediated Fibrinolysis and Nerve Remyelination

Area of Science:

• Neuroscience
• Cell Biology
• Regenerative Medicine

Background:

• a-disintegrin and metalloproteinase (ADAM)17 is known to regulate myelin formation in the peripheral nervous system.
• The role of ADAM17 in Wallerian degeneration (WD), the process of nerve self-repair following injury, was previously uninvestigated.

Purpose of the Study:

• To investigate the role of ADAM17 in the process of Wallerian degeneration and subsequent remyelination.
• To elucidate the molecular mechanisms by which ADAM17 influences nerve regeneration.

Main Methods:

• Utilized mutant mice lacking functional ADAM17.
• Analyzed protein processing, gene expression (tissue plasminogen activator), fibrin accumulation, macrophage recruitment, and nerve conduction velocity.
• Investigated the interaction between ADAM17 and p75 neurotrophin receptor (p75NTR).

Main Results:

• Glial ADAM17, but not neuronal ADAM17, is essential for promoting remyelination during WD.
• ADAM17 regulates p75 neurotrophin receptor (p75NTR) processing, which in turn affects tissue plasminogen activator (tPA) expression and fibrin clearance.
• Absence of glial ADAM17 leads to delayed remyelination, impaired macrophage recruitment, and defective nerve conduction velocity.

Conclusions:

• Glial ADAM17 plays a critical, cell-autonomous role in promoting nerve regeneration and remyelination following injury.
• ADAM17 regulates p75NTR-mediated fibrinolysis, a key pathway for efficient Wallerian degeneration.
• Targeting the ADAM17-p75NTR signaling axis offers a potential therapeutic strategy for enhancing nerve repair.